Related Experiment Video
Updated: Aug 10, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Co-infection associated with SARS-CoV-2 and their management
Vivek P Chavda1, Aayushi B Patel2, Anjali Pandya3
1Department of Pharmaceutics & Pharmaceutical Technology, L M College of Pharmacy, Ahmedabad, Gujarat, 380009, India.
This review details long COVID complications, including organ damage and rare infections like mucormycosis. It also discusses risk factors and treatments for post-COVID-19 conditions and multisystem inflammatory syndrome in children (MIS-C).
Area of Science:
- Infectious Diseases
- Public Health
- Internal Medicine
Background:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) caused a global pandemic, leading to COVID-19.
- Many patients experience persistent symptoms and complications after acute infection, a condition known as long COVID.
- Unusual post-recovery illnesses and multisystem inflammatory syndrome in children (MIS-C) have been observed.
Purpose of the Study:
- To review the spectrum of issues following COVID-19 recovery.
- To identify risk factors associated with multiorgan damage.
- To explore treatment strategies for post-COVID-19 complications.
Main Methods:
- This is a review article.
- Literature search on COVID-19, long COVID, and associated conditions.
- Synthesis of information on reported cases, risk factors, and treatments.
Main Results:
- Post-COVID-19 recovery can involve persistent symptoms, multiorgan damage, and rare infections (e.g., mucormycosis, white fungus).
- "Happy hypoxia" and other systemic abnormalities are reported in recovered individuals.
- Multisystem inflammatory syndrome in children (MIS-C) is a significant concern.
Conclusions:
- Factors like uncontrolled steroid use, immunosuppression, diabetes, and inadequate post-recovery care may contribute to complications.
- Understanding and managing these diverse post-COVID-19 conditions is crucial.
- Further research is needed to elucidate mechanisms and optimize treatment for long COVID and MIS-C.
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Tonsillitis II: Management
Pneumonia III: Complications and Assessment
Endocarditis III: Medical Management

